{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:26:09Z","timestamp":1792873569000,"version":"4.5.0"},"reference-count":350,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["7200682"],"award-info":[{"award-number":["7200682"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007567","name":"City University of Hong Kong","doi-asserted-by":"publisher","award":["9610518"],"award-info":[{"award-number":["9610518"]}],"id":[{"id":"10.13039\/100007567","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Copper (Cu) is a vital element required for cellular growth and development; however, even slight changes in its homeostasis might lead to severe toxicity and deleterious medical conditions. Cancer patients are typically associated with higher Cu content in serum and tumor tissues, indicating increased demand of cancer cells for this micronutrient. Cu is known to readily cycle between the +1 and +2 oxidation state in biological systems. The mechanism of action of Cu complexes is typically based on their redox activity and induction of reactive oxygen species (ROS), leading to deadly oxidative stress. However, there are a number of other biomolecular mechanisms beyond ROS generation that contribute to the activity of anticancer Cu drug candidates. In this review, we discuss how interfering with intracellular Cu balance via either diet modification or addition of inorganic Cu supplements or Cu-modulating compounds affects tumor development, progression, and sensitivity to treatment modalities. We aim to provide the rationale for the use of Cu-depleting and Cu-overloading conditions to generate the best possible patient outcome with minimal toxicity. We also discuss the advantages of the use of pre-formed Cu complexes, such as Cu-(bis)thiosemicarbazones or Cu-N-heterocyclic thiosemicarbazones, in comparison with the in situ formed Cu complexes with metal-binding ligands. In this review, we summarize available clinical and mechanistic data on clinically relevant anticancer drug candidates, including Cu supplements, Cu chelators, Cu ionophores, and Cu complexes.<\/jats:p>","DOI":"10.3390\/biomedicines9080852","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:53:23Z","timestamp":1626868403000},"page":"852","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance"],"prefix":"10.3390","volume":"9","author":[{"given":"Maria V.","family":"Babak","sequence":"first","affiliation":[{"name":"Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong 999077, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyun","family":"Ahn","sequence":"additional","affiliation":[{"name":"Drug Discovery Lab, Department of Chemistry, City University of Hong Kong, 83 Tat Chee Avenue, Hong Kong 999077, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/food.19880320811","article-title":"The physiological role of copper and the problems of copper nutritional deficiency","volume":"32","author":"Wachnik","year":"1988","journal-title":"Food Nahrung"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/jn\/109.11.1979","article-title":"A conspectus of research on copper metabolism and requirements of man","volume":"109","author":"Mason","year":"1979","journal-title":"J. Nutr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"376327","DOI":"10.1155\/2013\/376327","article-title":"Indian traditional ayurvedic system of medicine and nutritional supplementation","volume":"2013","author":"Pandey","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/jn\/129.7.1251","article-title":"A delicate balance: Homeostatic control of copper uptake and distribution","volume":"129","author":"Lee","year":"1999","journal-title":"J. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1152\/physrev.1985.65.2.238","article-title":"Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin","volume":"65","author":"Cousins","year":"1985","journal-title":"Physiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ccr.2009.12.018","article-title":"Copper-related diseases: From chemistry to molecular pathology","volume":"254","author":"Crisponi","year":"2010","journal-title":"Coord. Chem. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"965S","DOI":"10.1093\/ajcn\/67.5.965S","article-title":"Copper transport","volume":"67","author":"Linder","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1039\/C6MT00105J","article-title":"Copper and conquer: Copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics","volume":"8","author":"Park","year":"2016","journal-title":"Metallomics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"118893","DOI":"10.1016\/j.bbamcr.2020.118893","article-title":"Copper metabolism as a unique vulnerability in cancer","volume":"1868","author":"Shanbhag","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/bmc-2015-0030","article-title":"Extended functional repertoire for human copper chaperones","volume":"7","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ijch.201600019","article-title":"A Copper Story: From Protein Folding and Metal Transport to Cancer","volume":"56","year":"2016","journal-title":"Isr. J. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Blockhuys, S., and Wittung-Stafshede, P. (2017). Roles of Copper-Binding Proteins in Breast Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18040871"},{"key":"ref_14","unstructured":"Culotta, V., and Scott, R.A. (2016). Metals in Cells, John Wiley & Sons."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101900","DOI":"10.1016\/j.redox.2021.101900","article-title":"Are trace element concentrations suitable biomarkers for the diagnosis of cancer?","volume":"42","author":"Lossow","year":"2021","journal-title":"Redox Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1005870918388","article-title":"Trace elements and superoxide dismutase in benign and malignant breast diseases","volume":"45","author":"Kavas","year":"1997","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a008977","article-title":"Toenail Trace Element Levels and Breast Cancer: A Prospective Study","volume":"144","author":"Garland","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10534-015-9899-8","article-title":"Metal concentrations in hair of patients with various head and neck cancers as a diagnostic aid","volume":"29","author":"Wozniak","year":"2016","journal-title":"Biometals"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bel\u2019skaya, L.V., Sarf, E.A., Shalygin, S.P., Postnova, T.V., and Kosenok, V.K. (2021). Potential Diagnostic Significance of Salivary Copper Determination in Breast Cancer Patients: A Pilot Study. Biol. Trace Elem. Res.","DOI":"10.1007\/s12011-021-02710-5"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15835","DOI":"10.1007\/s11356-020-08113-8","article-title":"Copper and zinc levels in plasma and cancerous tissues and their relation with expression of VEGF and HIF-1 in the pathogenesis of muscle invasive urothelial bladder cancer: A case-controlled clinical study","volume":"27","author":"Mortada","year":"2020","journal-title":"Environ. Sci. Pollut. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"126629","DOI":"10.1016\/j.jtemb.2020.126629","article-title":"Serum copper and zinc levels in breast cancer: A meta-analysis","volume":"62","author":"Feng","year":"2020","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1177\/0300060518798507","article-title":"Association between serum copper levels and lung cancer risk: A meta-analysis","volume":"46","author":"Zhang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jtemb.2017.09.024","article-title":"Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients","volume":"45","author":"Prescha","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/carcin\/bgx051","article-title":"Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort","volume":"38","author":"Stepien","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0168-8278(00)80277-9","article-title":"Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma","volume":"33","author":"Ebara","year":"2000","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10495-016-1261-2","article-title":"Calcitriol\u2013copper interaction leads to non enzymatic, reactive oxygen species mediated DNA breakage and modulation of cellular redox scavengers in hepatocellular carcinoma","volume":"21","author":"Rizvi","year":"2016","journal-title":"Apoptosis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105109","DOI":"10.1016\/j.envint.2019.105109","article-title":"Association between serum heavy metals and prostate cancer risk\u2014A multiple metal analysis","volume":"132","author":"Lim","year":"2019","journal-title":"Environ. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12011-014-0123-4","article-title":"Comparative study of trace elements in blood, scalp hair and nails of prostate cancer patients in relation to healthy donors","volume":"162","author":"Qayyum","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.2174\/0929867326666190918120209","article-title":"Copper Concentrations in Breast Cancer: A Systematic Review and Meta-Analysis","volume":"27","author":"Jouybari","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.2017.1","article-title":"Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans","volume":"116","author":"Stepien","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.envint.2019.04.021","article-title":"Circulating essential metals and lung cancer: Risk assessment and potential molecular effects","volume":"127","author":"Bai","year":"2019","journal-title":"Environ. Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zab\u0142ocka-S\u0142owi\u0144ska, K., Prescha, A., P\u0142aczkowska, S., Por\u0119bska, I., Kosacka, M., and Pawe\u0142czyk, K. (2021). Serum and Whole Blood Cu and Zn Status in Predicting Mortality in Lung Cancer Patients. Nutrients, 13.","DOI":"10.3390\/nu13010060"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/ijc.31991","article-title":"Serum copper and zinc levels at diagnosis and hepatocellular carcinoma survival in the Guangdong Liver Cancer Cohort","volume":"144","author":"Fang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, W., Wang, X., Luo, J., Chen, X., Ma, K., He, H., Li, W., and Cui, J. (2020). Serum Copper Level and the Copper-to-Zinc Ratio Could Be Useful in the Prediction of Lung Cancer and Its Prognosis: A Case-Control Study in Northeast China. Nutr. Cancer, 1\u20138.","DOI":"10.1080\/01635581.2020.1817957"},{"key":"ref_35","first-page":"1190","article-title":"Serum copper levels in different stages of breast cancer","volume":"7","author":"Shyamala","year":"2016","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jso.2930460311","article-title":"Serum trace elements and Cu\/Zn ratio in breast cancer patients","volume":"46","author":"Gupta","year":"1991","journal-title":"J. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1353\/pbm.1993.0004","article-title":"Regulation of the acute phase response by cytokines","volume":"36","author":"Kushner","year":"1993","journal-title":"Perspect. Biol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41467-020-14698-y","article-title":"Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis","volume":"11","author":"Liao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejim.2012.07.009","article-title":"Copper levels in patients with hematological malignancies","volume":"23","author":"Kaiafa","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF02873441","article-title":"Changes in serum copper levels in patients with malignant diseases undergoing radiotherapy","volume":"13","author":"Mali","year":"1998","journal-title":"Ind. J. Clin. Biochem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02790064","article-title":"Changes of serum copper and zinc levels in patients with nasopharyngeal carcinoma by radiotherapy","volume":"46","author":"Hsu","year":"1994","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/1097-0142(197607)38:1<244::AID-CNCR2820380136>3.0.CO;2-V","article-title":"Ceruloplasmin levels in sera from human patients with osteosarcoma","volume":"38","author":"Shifrine","year":"1976","journal-title":"Cancer"},{"key":"ref_43","first-page":"1296","article-title":"Ceruloplasmin as a marker of neoplastic activity in rabbits bearing the VX-2 carcinoma","volume":"38","author":"Gluckman","year":"1978","journal-title":"Cancer Res."},{"key":"ref_44","first-page":"134","article-title":"Alterations in serum levels of trace element in patients with breast cancer before and after chemotherapy","volume":"9","author":"Ahmadi","year":"2018","journal-title":"Casp. J. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1039\/C5MT00316D","article-title":"Medical applications of Cu, Zn, and S isotope effects","volume":"8","author":"Albarede","year":"2016","journal-title":"Metallomics"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1039\/C4MT00269E","article-title":"Copper isotope effect in serum of cancer patients. A pilot study","volume":"7","author":"Puisieux","year":"2015","journal-title":"Metallomics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1073\/pnas.1415151112","article-title":"Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients","volume":"112","author":"Balter","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"16389","DOI":"10.1038\/s41598-020-71764-7","article-title":"Cu and Zn isotope ratio variations in plasma for survival prediction in hematological malignancy cases","volume":"10","author":"Hastuti","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1039\/C4MT00260A","article-title":"Zinc isotopic compositions of breast cancer tissue","volume":"7","author":"Larner","year":"2015","journal-title":"Metallomics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1039\/c1mt00025j","article-title":"Isotopic evidence of unaccounted for Fe and Cu erythropoietic pathways","volume":"3","author":"Telouk","year":"2011","journal-title":"Metallomics"},{"key":"ref_51","first-page":"604","article-title":"Curcumin attenuated the lipid peroxidation and apoptotic liver injury in copper-overloaded rats","volume":"45","author":"Wan","year":"2007","journal-title":"Chin. J. Pediatrics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nut.2013.06.009","article-title":"Copper-induced alterations in rat brain depends on route of overload and basal copper levels","volume":"30","author":"Arnal","year":"2014","journal-title":"Nutrition"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"18585","DOI":"10.1007\/s11356-017-9503-6","article-title":"Alleviative effect of licorice on copper chloride-induced oxidative stress in the brain: Biochemical, histopathological, immunohistochemical, and genotoxic study","volume":"24","author":"Mostafa","year":"2017","journal-title":"Environ. Sci. Poll. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/jps.3030431206","article-title":"The Safety and Fate of Potassium Sodium Copper Chlorophyllin and Other Copper Compounds","volume":"43","author":"Harrisson","year":"1954","journal-title":"J. Am. Pharm. Ass. (Sci. Ed.)"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"16867","DOI":"10.18632\/aging.103585","article-title":"Oxidative stress, apoptosis and inflammatory responses involved in copper-induced pulmonary toxicity in mice","volume":"12","author":"Jian","year":"2020","journal-title":"Aging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12011-014-9970-2","article-title":"Evaluation of Bioaccumulation and Toxic Effects of Copper on Hepatocellular Structure in Mice","volume":"159","author":"Wang","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.1073\/pnas.1318431110","article-title":"Bioavailable copper modulates oxidative phosphorylation and growth of tumors","volume":"110","author":"Ishida","year":"2013","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.yrtph.2016.09.025","article-title":"Temporal kinetics of organ damage in copper toxicity: A histopathological correlation in rat model","volume":"81","author":"Kumar","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0015-6264(73)80366-9","article-title":"Dietary copper and the induction of neoplasms in the rat by acetylaminofluorene and dimethylnitrosamine","volume":"11","author":"Carlton","year":"1973","journal-title":"Food Cosmet. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1084\/jem.20.5.503","article-title":"The influence of various substances on the growth of mouse carcinoma","volume":"20","author":"Fleisher","year":"1914","journal-title":"J. Exp. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/bjc.1958.67","article-title":"The Effect of Copper Acetate on p-Dimethylaminoazobenzene Carcinogenesis in the Rat","volume":"12","author":"Howell","year":"1958","journal-title":"Br. J. Cancer"},{"key":"ref_62","first-page":"563","article-title":"Suppressive effect of concurrent administration of metal salts on carcinogenesis by 3\u2019-methyl-4-(dimethylamino)azobenzene, and the effect of these metals on aminoazo dye metabolism during carcinogenesis","volume":"64","author":"Yamane","year":"1973","journal-title":"Gan"},{"key":"ref_63","first-page":"240","article-title":"The effects of copper on liver tumor induction by p-dimethylaminoazobenzene","volume":"5","author":"Sharpless","year":"1946","journal-title":"Fed. Proc."},{"key":"ref_64","first-page":"455","article-title":"Effect of copper on hepatic tumors produced by 3-methyl-4-dimethylaminoazobenzene","volume":"52","author":"Pedrero","year":"1951","journal-title":"AMA Arch. Pathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jn\/63.2.301","article-title":"Dietary Copper Salts and Azo Dye Carcinogenesis","volume":"63","author":"King","year":"1957","journal-title":"J. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/bjc.1963.69","article-title":"The Effect of Copper Acetate on Biochemical Changes Induced in the Rat Liver by p-Dimethylaminoazobenzene","volume":"17","author":"Fare","year":"1963","journal-title":"Br. J. Cancer"},{"key":"ref_67","first-page":"1279","article-title":"The Effect of Dietary Copper on Rat Carcinogenesis by 3-Methoxy Dyes","volume":"24","author":"Fare","year":"1964","journal-title":"Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1289\/ehp.83493","article-title":"Some historical aspects of N-aryl carcinogens and their metabolic activation","volume":"49","author":"Miller","year":"1983","journal-title":"Environ. Health Perspect."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/bjc.1964.90","article-title":"Failure of copper to inhibit carcinogenesis by 2-aminofluorene","volume":"18","author":"Goodall","year":"1964","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/bjc.1969.73","article-title":"Effect of oral copper sulfate on 7,12-dimethylbenz(\u03b1)anthracene carcinogenesis in mice","volume":"23","author":"Burki","year":"1969","journal-title":"Br. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1423-0127-18-95","article-title":"Effect of Cu supplementation on genomic instability in chemically-induced mammary carcinogenesis in the rat","volume":"18","author":"Bobrowska","year":"2011","journal-title":"J. Biomed. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12011-013-9854-x","article-title":"Copper and resveratrol attenuates serum catalase, glutathione peroxidase, and element values in rats with DMBA-induced mammary carcinogenesis","volume":"156","author":"Skrajnowska","year":"2013","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper is required for oncogenic BRAF signalling and tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Choi, R., Kim, M.-J., Sohn, I., Kim, S., Kim, I., Ryu, J.M., Choi, H.J., Kim, J.-M., Lee, S.K., and Yu, J. (2018). Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients. Nutrients, 11.","DOI":"10.3390\/nu11010037"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/BTER:89:1:1","article-title":"Serum and tissue trace elements in patients with breast cancer in Taiwan","volume":"89","author":"Kuo","year":"2002","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0891-5849(90)90156-D","article-title":"Free radicals, antioxidant enzymes, and carcinogenesis","volume":"8","author":"Sun","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/jn\/123.11.1939","article-title":"AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet","volume":"123","author":"Reeves","year":"1993","journal-title":"J. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(00)00531-0","article-title":"Inadequate dietary copper increases tumorigenesis in the Min mouse","volume":"159","author":"Davis","year":"2000","journal-title":"Cancer Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/jn\/129.5.1060","article-title":"Dietary copper, manganese and iron affect the formation of aberrant crypts in colon of rats administered 3,2\u2019-dimethyl-4-aminobiphenyl","volume":"129","author":"Davis","year":"1999","journal-title":"J. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jn\/132.5.1018","article-title":"Dietary copper affects azoxymethane-induced intestinal tumor formation and protein kinase C isozyme protein and mRNA expression in colon of rats","volume":"132","author":"Davis","year":"2002","journal-title":"J. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/biof.5520150102","article-title":"Dietary copper and dimethylhydrazine affect protein kinase C isozyme protein and mRNA expression and the formation of aberrant crypts in colon of rats","volume":"15","author":"Davis","year":"2001","journal-title":"Biofactors"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11596-013-1074-2","article-title":"Copper ions stimulate the proliferation of hepatic stellate cells via oxygen stress in vitro","volume":"33","author":"Xu","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bbagen.2012.03.007","article-title":"Cytotoxic effects of copper overload on human-derived lung and liver cells in culture","volume":"1820","author":"Arnal","year":"2012","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/096032700678815963","article-title":"Copper toxicity affects proliferation and viability of human hepatoma cells (HepG2 line)","volume":"19","author":"Aston","year":"2000","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A","article-title":"Copper stimulates proliferation of human endothelial cells under culture","volume":"69","author":"Hu","year":"1998","journal-title":"J. Cell. Biochem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1074\/jbc.M709463200","article-title":"Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation","volume":"283","author":"Itoh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000226711","article-title":"Localization of tissue copper in mouse mammary tumors","volume":"46","author":"Fuchs","year":"1989","journal-title":"Oncology"},{"key":"ref_88","first-page":"1502","article-title":"Distribution of copper-64 in control mice and in mice bearing ascitic Krebs tumor cells","volume":"41","author":"Apelgot","year":"1981","journal-title":"Cancer Res."},{"key":"ref_89","first-page":"761","article-title":"Quantitative and histochemical analysis of Cu, Zn, and Fe in spontaneous and induced primary tumors of rats","volume":"21","author":"Arnold","year":"1961","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Jana, A., Das, A., Krett, N.L., Guzman, G., Thomas, A., Mancinelli, G., Bauer, J., Ushio-Fukai, M., Fukai, T., and Jung, B. (2020). Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227916"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1073\/pnas.1910722117","article-title":"Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration","volume":"117","author":"Blockhuys","year":"2020","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.exphem.2005.06.015","article-title":"Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells","volume":"33","author":"Peled","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.0007-1048.2001.03316.x","article-title":"Cellular copper content modulates differentiation and self-renewal in cultures of cord blood-derived CD34+ cells","volume":"116","author":"Peled","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3727\/096368909X471152","article-title":"Copper modulates the differentiation of mouse hematopoietic progenitor cells in culture","volume":"18","author":"Huang","year":"2009","journal-title":"Cell Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.exphem.2004.03.002","article-title":"Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD\/SCID mice","volume":"32","author":"Peled","year":"2004","journal-title":"Exp. Hematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/14653240410004916","article-title":"Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine","volume":"6","author":"Peled","year":"2004","journal-title":"Cytotherapy"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajh.2830030209","article-title":"Observations on the anemia and neutropenia of human copper deficiency","volume":"3","author":"Zidar","year":"1977","journal-title":"Am. J. Hematol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jcb.10111","article-title":"Modulation of the proliferation and differentiation of human mesenchymal stem cells by copper","volume":"85","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mito.2016.04.005","article-title":"Non-cytotoxic copper overload boosts mitochondrial energy metabolism to modulate cell proliferation and differentiation in the human erythroleukemic cell line K562","volume":"29","author":"Ruiz","year":"2016","journal-title":"Mitochondrion"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0955-2863(94)90080-9","article-title":"Copper uptake and intracellular distribution during retinoic acid-induced differentiation of HL-60 cells","volume":"5","author":"Bae","year":"1994","journal-title":"J. Nutr. Biochem."},{"key":"ref_101","first-page":"997","article-title":"Retinoic acid-induced HL-60 cell differentiation is augmented by copper supplementation","volume":"123","author":"Bae","year":"1993","journal-title":"J. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1248\/jhs.52.540","article-title":"Copper is Required for Retinoic Acid Receptor-Dependent Transcription and Neuronal Differentiation in P19 Embryonal Carcinoma Cells","volume":"52","author":"Watanabe","year":"2006","journal-title":"J. Health Sci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1039\/C8MT00182K","article-title":"Copper-induced cell death and the protective role of glutathione: The implication of impaired protein folding rather than oxidative stress","volume":"10","author":"Andrieux","year":"2018","journal-title":"Metallomics"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbiotec.2014.08.001","article-title":"Proteomics analysis of altered cellular metabolism induced by insufficient copper level","volume":"189","author":"Kang","year":"2014","journal-title":"J. Biotechnol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/btpr.630","article-title":"Cell culture and gene transcription effects of copper sulfate on Chinese hamster ovary cells","volume":"27","author":"Qian","year":"2011","journal-title":"Biotechnol. Prog."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/btpr.1868","article-title":"Effects of copper on CHO cells: Insights from gene expression analyses","volume":"30","author":"Yuk","year":"2014","journal-title":"Biotechnol. Prog."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/bit.23291","article-title":"Comparative metabolite analysis to understand lactate metabolism shift in Chinese hamster ovary cell culture process","volume":"109","author":"Luo","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/btpr.2131","article-title":"Elucidating the role of copper in CHO cell energy metabolism using 13C metabolic flux analysis","volume":"31","author":"Nargund","year":"2015","journal-title":"Biotechnol. Prog."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0009-8981(80)90390-3","article-title":"The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates","volume":"104","author":"Habib","year":"1980","journal-title":"Clin. Chim. Acta"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-9120(98)00096-4","article-title":"Association between oxidative stress and changes of trace elements in patients with breast cancer","volume":"32","author":"Huang","year":"1999","journal-title":"Clin. Biochem."},{"key":"ref_111","first-page":"108","article-title":"Copper and ceruloplasmin status in serum of prostate and colon cancer patients","volume":"47","author":"Nayak","year":"2003","journal-title":"Indian J. Physiol. Pharm."},{"key":"ref_112","first-page":"5390","article-title":"Comparison between concentrations of trace elements in normal and neoplastic human breast tissue","volume":"44","author":"Rizk","year":"1984","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01731643","article-title":"Serum ceruloplasmin and copper levels in patients with primary brain tumors","volume":"62","author":"Kalina","year":"1984","journal-title":"Klin. Wochenschr."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/jcb.22231","article-title":"Synchrotron X-ray imaging reveals a correlation of tumor copper speciation with Clioquinol\u2019s anticancer activity","volume":"108","author":"Barrea","year":"2009","journal-title":"J. Cell Biochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1038\/s41467-020-17549-y","article-title":"Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer","volume":"11","author":"Aubert","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1822123","DOI":"10.1080\/23723556.2020.1822123","article-title":"Targeting copper metabolism to defeat KRAS-driven colorectal cancer","volume":"7","author":"Aubert","year":"2020","journal-title":"Mol. Cell. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5306\/wjco.v7.i1.106","article-title":"Role of copper transporters in platinum resistance","volume":"7","author":"Kilari","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"ref_119","first-page":"227","article-title":"Copper levels and the adriamycin inhibition of proliferating cells","volume":"10","author":"Iyengar","year":"1983","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10534-008-9174-3","article-title":"The role of copper in drug-resistant murine and human tumors","volume":"22","author":"Majumder","year":"2008","journal-title":"BioMetals"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2010.3663","article-title":"Anticancer activity of metal complexes: Involvement of redox processes","volume":"15","author":"Jungwirth","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9639","DOI":"10.1074\/jbc.M209455200","article-title":"Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1","volume":"278","author":"Petris","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/j.1460-2075.1996.tb00720.x","article-title":"Copper-dependent degradation of the Saccharomyces cerevisiae plasma membrane copper transporter Ctr1p in the apparent absence of endocytosis","volume":"15","author":"Ooi","year":"1996","journal-title":"EMBO J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2004.09.007","article-title":"Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs","volume":"53","author":"Safaei","year":"2005","journal-title":"Critical Rev. Oncol. Hematol."},{"key":"ref_125","first-page":"1312","article-title":"Copper-transporting P-Type Adenosine Triphosphatase (ATP7B) Is Associated with Cisplatin Resistance","volume":"60","author":"Komatsu","year":"2000","journal-title":"Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.abb.2017.11.001","article-title":"Physiological serum copper concentrations found in malignancies cause unfolding induced aggregation of human serum albumin in vitro","volume":"636","author":"Rizvi","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5729710","DOI":"10.1155\/2019\/5729710","article-title":"The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression","volume":"2019","author":"Walczak","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Maci\u0105\u017cek-Jurczyk, M., Janas, K., Po\u017cycka, J., Szkudlarek, A., Rog\u00f3\u017c, W., Owczarzy, A., and Kulig, K. (2020). Human Serum Albumin Aggregation\/Fibrillation and its Abilities to Drugs Binding. Molecules, 25.","DOI":"10.3390\/molecules25030618"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"24306","DOI":"10.1074\/jbc.M109.026583","article-title":"The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells","volume":"284","author":"Tardito","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1021\/ja109413c","article-title":"Copper Binding Agents Acting as Copper Ionophores Lead to Caspase Inhibition and Paraptotic Cell Death in Human Cancer Cells","volume":"133","author":"Tardito","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"18530","DOI":"10.1074\/jbc.272.30.18530","article-title":"Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis","volume":"272","author":"Perry","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1582-4934.2011.01292.x","article-title":"A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling","volume":"16","author":"Gandin","year":"2012","journal-title":"J. Cell Mol. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41419-018-1102-z","article-title":"The thiosemicarbazone Me2NNMe2 induces paraptosis by disrupting the ER thiol redox homeostasis based on protein disulfide isomerase inhibition","volume":"9","author":"Hager","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/acs.organomet.9b00229","article-title":"Redox-Active Organoruthenium(II)\u2013 and Organoosmium(II)\u2013Copper(II) Complexes, with an Amidrazone\u2013Morpholine Hybrid and [CuICl2]\u2212 as Counteranion and Their Antiproliferative Activity","volume":"38","author":"Ohui","year":"2019","journal-title":"Organometallics"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.microc.2016.12.007","article-title":"Comparative in vitro investigation of anticancer copper chelating agents","volume":"136","author":"Mihucz","year":"2018","journal-title":"Microchem. J."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Qin, C., Liu, H., Chen, K., Hu, X., Ma, X., Lan, X., Zhang, Y., and Cheng, Z. (2014). Theranostics of Malignant Melanoma with 64CuCl2. J. Nucl. Med. Off. Publ. Soc. Nucl. Med., 55.","DOI":"10.2967\/jnumed.113.133850"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.molcel.2006.01.033","article-title":"XIAP Is a Copper Binding Protein Deregulated in Wilson\u2019s Disease and Other Copper Toxicosis Disorders","volume":"21","author":"Mufti","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4161\/cc.27922","article-title":"Copper is a potent inhibitor of both the canonical and non-canonical NF\u03baB pathways","volume":"13","author":"Kenneth","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acs.jmedchem.8b01031","article-title":"New Water-Soluble Copper(II) Complexes with Morpholine\u2013Thiosemicarbazone Hybrids: Insights into the Anticancer and Antibacterial Mode of Action","volume":"62","author":"Ohui","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.7244654","article-title":"Copper deficiency suppresses the immune response of mice","volume":"213","author":"Prohaska","year":"1981","journal-title":"Science"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ajcn\/45.5.997","article-title":"Immune dysfunction in rats fed a diet deficient in copper","volume":"45","author":"Koller","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0034-5288(18)31906-4","article-title":"Effects of dietary copper depletion on acute and delayed inflammatory responses in mice","volume":"37","author":"Jones","year":"1984","journal-title":"Res. Vet. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0034-5288(18)32485-8","article-title":"Some effects of copper deficiency on leucocyte function in sheep and cattle","volume":"31","author":"Jones","year":"1981","journal-title":"Res. Vet. Sci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/ajcn\/46.6.1035","article-title":"Dietary copper deficiency and autoimmunity in the NZB mouse","volume":"46","author":"Mulhern","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0271-5317(89)80070-3","article-title":"Superoxide dismutase activity and blastogenic response of lymphocytes from copper-deficient rats fed diets containing fructose or cornstarch","volume":"9","author":"Babu","year":"1989","journal-title":"Nutr. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0271-5317(87)80032-5","article-title":"Lymphoid cell functions during copper deficiency","volume":"7","author":"Davis","year":"1987","journal-title":"Nutr. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0271-5317(83)80084-0","article-title":"Thymic factor activity, lymphocyte stimulation response and antibody producing cells in copper deficiency","volume":"3","author":"Vyas","year":"1983","journal-title":"Nutr. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jn\/120.12.1692","article-title":"Respiratory burst and candidacidal activity of peritoneal macrophages are impaired in copper-deficient rats","volume":"120","author":"Babu","year":"1990","journal-title":"J. Nutr."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1158\/0008-5472.CAN-20-0471","article-title":"Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res."},{"key":"ref_150","first-page":"2442","article-title":"Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma","volume":"9","author":"Zhou","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1039\/C5DT00634A","article-title":"Pharmacological activity of metal binding agents that alter copper bioavailability","volume":"44","author":"Helsel","year":"2015","journal-title":"Dalton Trans."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/iub.253","article-title":"Metal ionophores\u2014An emerging class of anticancer drugs","volume":"61","author":"Ding","year":"2009","journal-title":"IUBMB Life"},{"key":"ref_153","unstructured":"Rosenberg, R.N., and Pascual, J.M. (2015). Chapter 40\u2014Wilson Disease. Rosenberg\u2019s Molecular and Genetic Basis of Neurological and Psychiatric Disease, Academic Press. [5th ed.]."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1039\/C5MT00149H","article-title":"Targeting copper in cancer therapy: \u2018Copper That Cancer\u2019","volume":"7","author":"Denoyer","year":"2015","journal-title":"Metallomics"},{"key":"ref_155","first-page":"200","article-title":"A Mechanism for the Action of Penicillamine in the Treatment of Wilson\u2019s Disease","volume":"5","author":"Peisach","year":"1969","journal-title":"Mol. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1534735402238185","article-title":"Cancer Therapy with Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper\u2014A Review","volume":"1","author":"Brewer","year":"2002","journal-title":"Integr. Cancer Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40257-013-0022-z","article-title":"Penicillamine revisited: Historic overview and review of the clinical uses and cutaneous adverse effects","volume":"14","author":"Ishak","year":"2013","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.ajpath.2013.06.026","article-title":"Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme Progression","volume":"183","author":"Mammoto","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_159","first-page":"1219","article-title":"In vitro and in vivo interactions of D-penicillamine with tumors","volume":"16","author":"Samoszuk","year":"1996","journal-title":"Anticancer Res."},{"key":"ref_160","first-page":"231","article-title":"Effects of D-Penicillamine on growth and metastasis of Lewis lung carcinoma","volume":"22","author":"Soldatkina","year":"2000","journal-title":"Exp. Oncol."},{"key":"ref_161","first-page":"1121","article-title":"Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor","volume":"137","author":"Brem","year":"1990","journal-title":"Am. J. Pathol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.freeradbiomed.2007.07.003","article-title":"Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells","volume":"43","author":"Gupte","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1215\/S1152851704000869","article-title":"Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma","volume":"7","author":"Brem","year":"2005","journal-title":"Neuro-Oncol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1535-7163.MCT-10-0523","article-title":"Triethylenetetramine Pharmacology and Its Clinical Applications","volume":"9","author":"Lu","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fonc.2019.00437","article-title":"A Dose Escalation Study of Trientine Plus Carboplatin and Pegylated Liposomal Doxorubicin in Women With a First Relapse of Epithelial Ovarian, Tubal, and Peritoneal Cancer Within 12 Months After Platinum-Based Chemotherapy","volume":"9","author":"Huang","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jchromb.2007.09.001","article-title":"Determination of triethylenetetramine (TETA) and its metabolites in human plasma and urine by liquid chromatography-mass spectrometry (LC-MS)","volume":"859","author":"Lu","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1017\/S002185960004836X","article-title":"The teart pastures of Somerset: I. The cause and cure of teartness","volume":"33","author":"Ferguson","year":"1943","journal-title":"J. Agric. Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/S0021859600062468","article-title":"Thiomolybdates and the copper\u2013molybdenum\u2013sulphur interaction in ruminant nutrition","volume":"85","author":"Dick","year":"1975","journal-title":"J. Agric. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0162-0134(00)80041-0","article-title":"The copper-molybdenum antagonism in ruminants. I. The formation of thiomolybdates in animal rumen","volume":"12","author":"Clarke","year":"1980","journal-title":"J. Inorg. Biochem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0162-0134(00)80037-9","article-title":"Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate","volume":"14","author":"CF","year":"1981","journal-title":"J. Inorg. Biochem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1079\/BJN19810055","article-title":"An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep","volume":"46","author":"Gooneratne","year":"1981","journal-title":"Br. J. Nutr."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1568009053765807","article-title":"Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer","volume":"5","author":"Brewer","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_173","first-page":"4854","article-title":"Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis","volume":"62","author":"Pan","year":"2002","journal-title":"Cancer Res."},{"key":"ref_174","first-page":"1","article-title":"Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study","volume":"6","author":"Brewer","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_175","first-page":"1666","article-title":"Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer","volume":"9","author":"Redman","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000106066","article-title":"Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer","volume":"71","author":"Henry","year":"2006","journal-title":"Oncology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/mmt-2015-0005","article-title":"Copper suppression as cancer therapy: The rationale for copper chelating agents in BRAF(V600) mutated melanoma","volume":"3","author":"Sammons","year":"2016","journal-title":"Melanoma Manag."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Lopez, J., Ramchandani, D., and Vahdat, L. (2019). Copper Depletion as a Therapeutic Strategy in Cancer. Met. Ions Life Sci., 19.","DOI":"10.1515\/9783110527872-012"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/np990514f","article-title":"Aminosterols from the dogfish shark Squalus acanthias","volume":"63","author":"Rao","year":"2000","journal-title":"J. Nat. Prod."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/oby.2009.444","article-title":"Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice","volume":"18","author":"Lantz","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/febs.12077","article-title":"Protein tyrosine phosphatases--from housekeeping enzymes to master regulators of signal transduction","volume":"280","author":"Tonks","year":"2013","journal-title":"FEBS J."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/febs.14724","article-title":"PTP1B markedly promotes breast cancer progression and is regulated by miR-193a-3p","volume":"286","author":"Yu","year":"2019","journal-title":"FEBS J."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbapap.2009.09.018","article-title":"The two faces of PTP1B in cancer","volume":"1804","author":"Lessard","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1074\/jbc.C117.819110","article-title":"A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models","volume":"293","author":"Krishnan","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Babak, M.V., Airey, M., and Hartinger, C.G. (2015). Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and Ligands. Kinomics: Approaches and Applications, John Wiley & Sons.","DOI":"10.1002\/9783527683031.ch13"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Cen","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"De Sousa, A. (2019). Disulfiram: Pharmacology and Mechanism of Action. Disulfiram: Its Use in Alcohol Dependence and Other Disorders, Springer Singapore.","DOI":"10.1007\/978-981-32-9876-7"},{"key":"ref_190","first-page":"47","article-title":"Spontaneous regression of breast cancer","volume":"12","author":"Lewison","year":"1977","journal-title":"Prog. Clin. Biol. Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2147\/CMAR.S308168","article-title":"Overview of Antabuse\u00ae (Disulfiram) in Radiation and Cancer Biology","volume":"13","author":"Jia","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1158\/0008-5472.CAN-13-3527","article-title":"Copper Signaling Axis as a Target for Prostate Cancer Therapeutics","volume":"74","author":"Safi","year":"2014","journal-title":"Cancer Res."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-15-1798","article-title":"Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma","volume":"22","author":"Lun","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1039\/C4CC04767B","article-title":"On the interaction of copper(ii) with disulfiram","volume":"50","author":"Lewis","year":"2014","journal-title":"Chem. Comm."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2174\/138955712802762068","article-title":"Diethyldithiocarbamate complex with copper: The mechanism of action in cancer cells","volume":"12","author":"Skrott","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Meraz-Torres, F., Pl\u00f6ger, S., Garbe, C., Niessner, H., and Sinnberg, T. (2020). Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?. Cancers, 12.","DOI":"10.3390\/cancers12123538"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/pcan.2013.28","article-title":"Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer","volume":"16","author":"Schweizer","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.18632\/oncotarget.707","article-title":"High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells","volume":"3","author":"Hothi","year":"2012","journal-title":"Oncotarget"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/bjc.2012.442","article-title":"Cytotoxic effect of disulfiram\/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells","volume":"107","author":"Liu","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2967\/jnumed.113.131797","article-title":"PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model","volume":"55","author":"Nomura","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Butcher, K., Kannappan, V., Kilari, R.S., Morris, M.R., McConville, C., Armesilla, A.L., and Wang, W. (2018). Investigation of the key chemical structures involved in the anticancer activity of disulfiram in A549 non-small cell lung cancer cell line. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4617-x"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1038\/s41598-018-21768-1","article-title":"The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1\/2 signaling","volume":"8","author":"Yang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/CAD.0b013e3282f2bdff","article-title":"Potent anticancer activity of pyrrolidine dithiocarbamate\u2013copper complex against cisplatin-resistant neuroblastoma cells","volume":"19","author":"Zhang","year":"2008","journal-title":"Anti-Cancer Drugs"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"R897","DOI":"10.1186\/bcr1322","article-title":"Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells","volume":"7","author":"Daniel","year":"2005","journal-title":"Breast Cancer Res."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.canlet.2010.09.010","article-title":"A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells","volume":"300","author":"Wang","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"104346","DOI":"10.1016\/j.bioorg.2020.104346","article-title":"An insight into medicinal attributes of dithiocarbamates: Bird\u2019s eye view","volume":"105","author":"Shinde","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2008.08.015","article-title":"The toxicology of Clioquinol","volume":"182","author":"Mao","year":"2008","journal-title":"Toxicol. Lett."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1755-5949.2010.00231.x","article-title":"Clioquinol: Review of its mechanisms of action and clinical uses in neurodegenerative disorders","volume":"18","author":"Bareggi","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-06-3546","article-title":"Clioquinol, a therapeutic agent for Alzheimer\u2019s disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1158\/0008-5472.CAN-04-3577","article-title":"Anticancer Activity of the Antibiotic Clioquinol","volume":"65","author":"Ding","year":"2005","journal-title":"Cancer Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits \u03b2-Amyloid Accumulation in Alzheimer\u2019s Disease Transgenic Mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/leu.2008.232","article-title":"Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma","volume":"23","author":"Mao","year":"2009","journal-title":"Leukemia"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1016\/j.bmc.2009.08.054","article-title":"Synthesis and pharmacological exploitation of clioquinol-derived copper-binding apoptosis inducers triggering reactive oxygen species generation and MAPK pathway activation","volume":"17","author":"Chen","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Dalzon, B., Bons, J., Diemer, H., Collin-Faure, V., Marie-Desvergne, C., Dubosson, M., Cianferani, S., Carapito, C., and Rabilloud, T. (2019). A Proteomic View of Cellular Responses to Anticancer Quinoline-Copper Complexes. Proteomes, 7.","DOI":"10.3390\/proteomes7020026"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41416-019-0609-0","article-title":"Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies","volume":"121","author":"Kita","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Pape, V.F.S., Ga\u00e1l, A., Szatm\u00e1ri, I., Kucsma, N., Szoboszlai, N., Streli, C., F\u00fcl\u00f6p, F., Enyedy \u00c9, A., and Szak\u00e1cs, G. (2021). Relation of Metal-Binding Property and Selective Toxicity of 8-Hydroxyquinoline Derived Mannich Bases Targeting Multidrug Resistant Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13010154"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-19-1407","article-title":"Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein-Expressing Cells","volume":"80","author":"Cserepes","year":"2020","journal-title":"Cancer Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"8293","DOI":"10.1158\/0008-5472.CAN-09-2422","article-title":"Identification of compounds selectively killing multidrug-resistant cancer cells","volume":"69","author":"Hall","year":"2009","journal-title":"Cancer Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1016\/j.bmcl.2013.07.032","article-title":"Syntheses and antitumor activities of N\u20321,N\u20323-dialkyl-N\u20321,N\u20323-di-(alkylcarbonothioyl) malonohydrazide: The discovery of elesclomol","volume":"23","author":"Chen","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.04.013","article-title":"Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II), Ni(II) and Pt(II)","volume":"126","author":"Yadav","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpba.2010.09.007","article-title":"LC-MS\/MS and density functional theory study of copper(II) and nickel(II) chelating complexes of elesclomol (a novel anticancer agent)","volume":"54","author":"Wu","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.freeradbiomed.2012.03.017","article-title":"The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells","volume":"52","author":"Nagai","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-019-0291-9","article-title":"Mitochondrial metabolism promotes adaptation to proteotoxic stress","volume":"15","author":"Tsvetkov","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1200\/JCO.2008.17.1579","article-title":"Phase II, randomized, controlled, double-blinded trial of weekly elesclomol plus paclitaxel versus paclitaxel alone for stage IV metastatic melanoma","volume":"27","author":"Gonzalez","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1200\/JCO.2012.44.5585","article-title":"Final results of phase III SYMMETRY study: Randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma","volume":"31","author":"Eggermont","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2018.10.001","article-title":"A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology\/gynecologic oncology group study","volume":"151","author":"Monk","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ccr.2019.02.013","article-title":"Coordination chemistry of S-substituted isothiosemicarbazides and isothiosemicarbazones","volume":"387","author":"Arion","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ccr.2008.07.004","article-title":"Bonding and structure trends of thiosemicarbazone derivatives of metals\u2014An overview","volume":"253","author":"Lobana","year":"2009","journal-title":"Coord. Chem. Rev."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.4155\/fmc.09.80","article-title":"Thiosemicarbazones: The new wave in cancer treatment","volume":"1","author":"Kalinowski","year":"2009","journal-title":"Future Med. Chem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","article-title":"Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors","volume":"52","author":"Yu","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1039\/c0cs00215a","article-title":"Copper complexes of bis(thiosemicarbazones): From chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals","volume":"40","author":"Paterson","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development","volume":"30","author":"Heffeter","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1021\/jm00098a012","article-title":"Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone","volume":"35","author":"Liu","year":"1992","journal-title":"J. Med. Chem."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6468(08)70451-X","article-title":"1 Chemical and Biological Properties of Cytotoxic \u03b1-(N)-Heterocyclic Carboxaldehyde Thiosemicarbazones","volume":"Volume 32","author":"Ellis","year":"1995","journal-title":"Progress in Medicinal Chemistry"},{"key":"ref_235","first-page":"402","article-title":"Examination of the antiproliferative activity of iron chelators: Multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311","volume":"9","author":"Chaston","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bcp.2014.08.006","article-title":"Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes","volume":"91","author":"Ishiguro","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.inoche.2004.12.016","article-title":"Indirect evidences of desulfurization of a thiosemicarbazonecopper(II) system in aqueous basic medium","volume":"8","author":"Pizarro","year":"2005","journal-title":"Inorg. Chem. Commun."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/ejic.200901174","article-title":"Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3-Aminopyridine-2-carbaldehyde Thiosemicarbazone) and Related Ligands","volume":"2010","author":"Enyedy","year":"2010","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1021\/jm900528d","article-title":"Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation","volume":"52","author":"Kowol","year":"2009","journal-title":"J. Med. Chem."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/jm100561b","article-title":"Novel Thiosemicarbazones of the ApT and DpT Series and Their Copper Complexes: Identification of Pronounced Redox Activity and Characterization of Their Antitumor Activity","volume":"53","author":"Jansson","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jinorgbio.2013.09.016","article-title":"Complex forming competition and in-vitro toxicity studies on the applicability of di-2-pyridylketone-4,4,-dimethyl-3-thiosemicarbazone (Dp44mT) as a metal chelator","volume":"130","author":"Mihucz","year":"2014","journal-title":"J. Inorg. Biochem."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jtemb.2018.01.011","article-title":"Metal transport capabilities of anticancer copper chelators","volume":"47","author":"Mihucz","year":"2018","journal-title":"J. Trace Elem. Med. Biol."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.leukres.2005.12.013","article-title":"Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome","volume":"30","author":"Yee","year":"2006","journal-title":"Leuk. Res."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ygyno.2013.04.019","article-title":"Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers","volume":"130","author":"Kunos","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/mol.111.073627","article-title":"Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: A new strategy for the treatment of pancreatic cancer","volume":"80","author":"Kovacevic","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"42411","DOI":"10.18632\/oncotarget.6389","article-title":"Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents","volume":"6","author":"Sestak","year":"2015","journal-title":"Oncotarget"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1021\/jm300768u","article-title":"Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo","volume":"55","author":"Lovejoy","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","article-title":"Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes","volume":"71","author":"Lovejoy","year":"2011","journal-title":"Cancer Res."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1074\/jbc.M115.682450","article-title":"Glucose Modulation Induces Lysosome Formation and Increases Lysosomotropic Drug Sequestration via the P-Glycoprotein Drug Transporter","volume":"291","author":"Seebacher","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1021\/jm101532u","article-title":"Role of Metalation in the Topoisomerase II\u03b1 Inhibition and Antiproliferation Activity of a Series of \u03b1-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II) Complexes","volume":"54","author":"Zeglis","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"33568","DOI":"10.1074\/jbc.M114.599480","article-title":"The anticancer agent di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes prosurvival autophagy by two mechanisms: Persistent induction of autophagosome synthesis and impairment of lysosomal integrity","volume":"289","author":"Gutierrez","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1074\/jbc.M114.631283","article-title":"Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)","volume":"290","author":"Jansson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/1873-3468.13967","article-title":"An inventory of lysosomal ABC transporters","volume":"594","author":"Szakacs","year":"2020","journal-title":"FEBS Lett."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1021\/jm00197a017","article-title":"2-Acetylpyridine thiosemicarbazones. 2. N4,N4-Disubstituted derivatives as potential antimalarial agents","volume":"22","author":"Klayman","year":"1979","journal-title":"J. Med. Chem."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.18.2.317","article-title":"Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro","volume":"18","author":"Casero","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_257","first-page":"1349","article-title":"Correlations between structure and antimycobacterial activity in a series of 2-acetylpyridine thiosemicarbazones","volume":"128","author":"Collins","year":"1982","journal-title":"J. Gen. Microbiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0166-3542(86)90002-1","article-title":"Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model","volume":"6","author":"Shipman","year":"1986","journal-title":"Antivir. Res."},{"key":"ref_259","unstructured":"Klayman, D.L., and Scovill, J.P. (1987). Preparation of 2-acetyl- and 2-propionylpyridine Selenosemicarbazones as Antimalarial and Antileukemic Agents. (US4665173A)."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ccr.2012.03.042","article-title":"Allele-Specific p53 Mutant Reactivation","volume":"21","author":"Yu","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1158\/1078-0432.CCR-18-0822","article-title":"Zinc Metallochaperones Reactivate Mutant p53 Using an ON\/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics","volume":"24","author":"Yu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1124\/mol.116.107409","article-title":"Thiosemicarbazones Functioning as Zinc Metallochaperones to Reactivate Mutant p53","volume":"91","author":"Yu","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.chembiol.2018.02.010","article-title":"Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells","volume":"25","author":"Shimada","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1158\/1535-7163.MCT-18-1080","article-title":"Combinatorial therapy of zinc metallochaperones with mutant p53 reactivation and diminished copper binding","volume":"18","author":"Zaman","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acs.jmedchem.0c01360","article-title":"Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53","volume":"64","author":"Gilleran","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10549-019-05435-1","article-title":"COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells","volume":"179","author":"Synnott","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1158\/1078-0432.CCR-19-0096","article-title":"COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms","volume":"25","author":"Lindemann","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0959-8049(16)32638-7","article-title":"38\u2014COTI-2, a new anticancer drug currently under clinical investigation, targets mutant p53 and negatively modulates the PI3K\/AKT\/mTOR pathway","volume":"69","author":"Salim","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"41363","DOI":"10.18632\/oncotarget.9133","article-title":"COTI-2, a novel small molecule that is active against multiple human cancer cell lines in vitro and in vivo","volume":"7","author":"Salim","year":"2016","journal-title":"Oncotarget"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Maleki Vareki, S., Salim, K.Y., Danter, W.R., and Koropatnick, J. (2018). Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191766"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"13719","DOI":"10.1021\/acs.jmedchem.0c01277","article-title":"Cancer Cell Resistance Against the Clinically Investigated Thiosemicarbazone COTI-2 Is Based on Formation of Intracellular Copper Complex Glutathione Adducts and ABCC1-Mediated Efflux","volume":"63","author":"Hager","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_272","first-page":"1115","article-title":"The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone)","volume":"27","author":"Petering","year":"1967","journal-title":"Cancer Res."},{"key":"ref_273","first-page":"1278","article-title":"The Antitumor Activity of Cu(II)KTS, the Copper(II) Chelate of 3-Ethoxy-2-oxobutyraldehyde Bis(thiosemicarbazone)","volume":"27","author":"Crim","year":"1967","journal-title":"Cancer Res."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1021\/jm00310a013","article-title":"Metal complexes of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone) and related ligands as antitumor agents","volume":"11","author":"Petering","year":"1968","journal-title":"J. Med. Chem."},{"key":"ref_275","first-page":"1417","article-title":"Kethoxal Bis(thiosemicarbazone)","volume":"25","author":"Mihich","year":"1965","journal-title":"Cancer Res."},{"key":"ref_276","first-page":"290","article-title":"Metabolic Effects of Copper in Intact Cells: Comparative Activity of Cupric Chloride and the Cupric Chelate of Kethoxal Bis(thiosemicarbazone)","volume":"3","author":"Booth","year":"1967","journal-title":"Mol. Pharmacol."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0006-3061(00)80227-6","article-title":"Reactions of Bis(thiosemicarbazonato) Copper(II) complexes with tumor cells and mitochondria","volume":"6","author":"Minkel","year":"1976","journal-title":"Bioinorg. Chem."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/217250a0","article-title":"Sites of Inhibition of DNA Synthesis by Kethoxal bis(Thiosemicarbazone)","volume":"217","author":"Booth","year":"1968","journal-title":"Nature"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/ja00235a007","article-title":"Orientation and mobility of a copper square-planar complex in a lipid bilayer","volume":"109","author":"Subczynski","year":"1987","journal-title":"J. Am. Chem. Soc."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0006-3061(00)80074-5","article-title":"Comparative properties of the antineoplastic agent, 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II) and related chelates: Linear free energy correlations","volume":"3","author":"Winkelmann","year":"1974","journal-title":"Bioinorg. Chem."},{"key":"ref_281","first-page":"124","article-title":"Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells","volume":"38","author":"Minkel","year":"1978","journal-title":"Cancer Res."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1021\/cb400198p","article-title":"Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells","volume":"8","author":"Cater","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1073\/pnas.1116227108","article-title":"An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copper(II)","volume":"109","author":"Donnelly","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/BJ20070705","article-title":"Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake","volume":"407","author":"Folmer","year":"2007","journal-title":"Biochem. J."},{"key":"ref_285","first-page":"1155","article-title":"Copper-62-ATSM: A new hypoxia imaging agent with high membrane permeability and low redox potential","volume":"38","author":"Fujibayashi","year":"1997","journal-title":"J. Nucl. Med."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Fujibayashi, Y., Yoshii, Y., Furukawa, T., Yoshimoto, M., Matsumoto, H., and Saga, T. (2020). Imaging and Therapy against Hypoxic Tumors with 64Cu-ATSM. Make Life Visible, Springer.","DOI":"10.1007\/978-981-13-7908-6_29"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11094-009-0162-x","article-title":"Antitumor activity of substituted methylglyoxal bisthiosemicarbazones and their copper(II) chelates","volume":"42","author":"Dilanyan","year":"2008","journal-title":"Pharm. Chem. J."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1021\/jacs.8b08014","article-title":"A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals","volume":"140","author":"Su","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1021\/acs.jmedchem.6b00342","article-title":"Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention","volume":"59","author":"Kowol","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/ars.2019.7854","article-title":"High Copper Complex Stability and Slow Reduction Kinetics as Key Parameters for Improved Activity, Paraptosis Induction, and Impact on Drug-Resistant Cells of Anticancer Thiosemicarbazones","volume":"33","author":"Hager","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1039\/c9mt00061e","article-title":"Reactivity of Cu(ii)\u2013, Zn(ii)\u2013 and Fe(ii)\u2013thiosemicarbazone complexes with glutathione and metallothionein: From stability to dissociation to transmetallation","volume":"11","author":"Santoro","year":"2019","journal-title":"Metallomics"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae\u2014The first FDA-approved nano-drug: Lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12951-016-0193-x","article-title":"Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy","volume":"14","author":"Piktel","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1039\/C7DT00283A","article-title":"Copper(ii) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells","volume":"46","author":"Palamarciuc","year":"2017","journal-title":"Dalton Trans."},{"key":"ref_295","doi-asserted-by":"crossref","unstructured":"Ohui, K., Stepanenko, I., Besleaga, I., Babak, M.V., Stafi, R., Darvasiova, D., Giester, G., P\u00f3sa, V., Enyedy, E.A., and Vegh, D. (2020). Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells. Biomolecules, 10.","DOI":"10.3390\/biom10091336"},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13346-017-0455-7","article-title":"Development of a copper-clioquinol formulation suitable for intravenous use","volume":"8","author":"Wehbe","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_297","doi-asserted-by":"crossref","unstructured":"Ga\u00e1l, A., Garay, T.M., Horv\u00e1th, I., M\u00e1th\u00e9, D., Sz\u00f6ll\u0151si, D., Veres, D.S., Mbuotidem, J., Kov\u00e1cs, T., T\u00f3v\u00e1ri, J., and Bergmann, R. (2020). Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050466"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","article-title":"Mitochondrial copper depletion suppresses triple-negative breast cancer in mice","volume":"39","author":"Cui","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10495-012-0746-x","article-title":"D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis","volume":"17","author":"Qiao","year":"2012","journal-title":"Apoptosis"},{"key":"ref_300","doi-asserted-by":"crossref","unstructured":"Crowe, A., Jackaman, C., Beddoes, K.M., Ricciardo, B., and Nelson, D.J. (2013). Rapid Copper Acquisition by Developing Murine Mesothelioma: Decreasing Bioavailable Copper Slows Tumor Growth, Normalizes Vessels and Promotes T Cell Infiltration. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073684"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bcp.2015.03.006","article-title":"Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo","volume":"95","author":"Chen","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.10740","article-title":"The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production","volume":"102","author":"Moriguchi","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1292\/jvms.001541","article-title":"Trientine, a Copper-Chelating Agent, Induced Apoptosis in Murine Fibrosarcoma Cells by Activation of the p38 MAPK Pathway","volume":"71","author":"Kadowaki","year":"2009","journal-title":"J. Vet. Med. Sci."},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-008-0791-x","article-title":"Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer","volume":"63","author":"Brown","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10637-013-0051-8","article-title":"Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies","volume":"32","author":"Fu","year":"2014","journal-title":"Investig. New Drugs"},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1535-7163.MCT-11-0864","article-title":"Overcoming platinum resistance through the use of a copper-lowering agent","volume":"11","author":"Fu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-06-0171","article-title":"Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1","volume":"12","author":"Juarez","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/annonc\/mds654","article-title":"Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse","volume":"24","author":"Jain","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10637-012-9864-0","article-title":"Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer","volume":"31","author":"Schneider","year":"2013","journal-title":"Investig. New Drugs"},{"key":"ref_310","first-page":"581","article-title":"A non-comparative randomized phase II study of 2 doses of ATN-224, a copper\/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naive prostate cancer","volume":"31","author":"Lin","year":"2013","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10637-008-9165-9","article-title":"A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer","volume":"27","author":"Gartner","year":"2009","journal-title":"Investig. New Drugs"},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CMR.0b013e328334131d","article-title":"Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma","volume":"20","author":"Morrison","year":"2010","journal-title":"Melanoma Res."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"key":"ref_314","doi-asserted-by":"crossref","unstructured":"Li, Y., Chen, F., Chen, J., Chan, S., He, Y., Liu, W., and Zhang, G. (2020). Disulfiram\/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS\/MAPK and Ferroptosis Pathways. Cancers, 12.","DOI":"10.3390\/cancers12010138"},{"key":"ref_315","doi-asserted-by":"crossref","unstructured":"Kelley, K.C., Grossman, K.F., Brittain-Blankenship, M., Thorne, K.M., Akerley, W.L., Terrazas, M.C., Kosak, K.M., Boucher, K.M., Buys, S.S., and McGregor, K.A. (2021). A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08242-4"},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Nechushtan","year":"2015","journal-title":"Oncologist"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.12688\/f1000research.16786.1","article-title":"Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial [version 1; referees: 2 approved]","volume":"7","author":"Jakola","year":"2018","journal-title":"F1000Research"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11060-019-03125-y","article-title":"A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma","volume":"142","author":"Huang","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00000421-199004000-00007","article-title":"A randomized phase II study of cisplatin alone versus cisplatin plus disulfiram","volume":"13","author":"Verma","year":"1990","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clml.2012.05.005","article-title":"A Phase I Study of the Metal Ionophore Clioquinol in Patients with Advanced Hematologic Malignancies","volume":"12","author":"Schimmer","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_321","doi-asserted-by":"crossref","unstructured":"Blackman, R.K., Cheung-Ong, K., Gebbia, M., Proia, D.A., He, S., Kepros, J., Jonneaux, A., Marchetti, P., Kluza, J., and Rao, P.E. (2012). Mitochondrial electron transport is the cellular target of the oncology drug elesclomol. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0029798"},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3109\/10428194.2016.1138293","article-title":"A phase I study of elesclomol sodium in patients with acute myeloid leukemia","volume":"57","author":"Hedley","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1158\/1078-0432.CCR-06-0964","article-title":"Phase I Clinical Trial of STA-4783 in Combination with Paclitaxel in Patients with Refractory Solid Tumors","volume":"13","author":"Berkenblit","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00280-010-1481-z","article-title":"Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer","volume":"68","author":"Ocean","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00280-011-1779-5","article-title":"A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: A California Cancer Consortium Study","volume":"69","author":"Chao","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1078-0432.CCR-09-2469","article-title":"Phase I Trial of Pelvic Radiation, Weekly Cisplatin, and 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone (3-AP, NSC #663249) for Locally Advanced Cervical Cancer","volume":"16","author":"Kunos","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10637-012-9863-1","article-title":"A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors","volume":"31","author":"Mortazavi","year":"2013","journal-title":"Investig. New Drugs"},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-008-9123-6","article-title":"A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas","volume":"26","author":"Attia","year":"2008","journal-title":"Investig. New Drugs"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/j.ijrobp.2012.06.003","article-title":"A Dose Escalation and Pharmacodynamic Study of Triapine and Radiation in Patients with Locally Advanced Pancreas Cancer","volume":"84","author":"Martin","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10637-009-9230-z","article-title":"A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503","volume":"28","author":"Traynor","year":"2010","journal-title":"Investig. New Drugs"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10637-008-9115-6","article-title":"Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia","volume":"26","author":"Odenike","year":"2008","journal-title":"Investig. New Drugs"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fonc.2018.00149","article-title":"Triapine Radiochemotherapy in Advanced Stage Cervical Cancer","volume":"8","author":"Kunos","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1479-5876-10-79","article-title":"Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: A Gynecologic Oncology Group Study","volume":"10","author":"Kunos","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00280-008-0890-8","article-title":"A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors","volume":"63","author":"Schelman","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_335","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1200\/jco.2006.24.18_suppl.12011","article-title":"A phase I study of triapine in combination with irinotecan in refractory tumors","volume":"24","author":"Schelman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3324\/haematol.2013.097246","article-title":"A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms","volume":"99","author":"Zeidner","year":"2014","journal-title":"Haematologica"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10637-007-9066-3","article-title":"A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium","volume":"25","author":"Mackenzie","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10637-007-9044-9","article-title":"Phase II study of Triapine in patients with metastatic renal cell carcinoma: A trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)","volume":"25","author":"Knox","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1200\/JCO.2004.07.158","article-title":"Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion","volume":"22","author":"Wadler","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.leukres.2007.01.004","article-title":"Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies","volume":"31","author":"Gojo","year":"2007","journal-title":"Leuk. Res."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.leukres.2007.05.003","article-title":"A phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders","volume":"32","author":"Karp","year":"2008","journal-title":"Leuk. Res."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10637-007-9085-0","article-title":"A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine\u00ae) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells","volume":"26","author":"Ma","year":"2008","journal-title":"Investig. New Drugs"},{"key":"ref_343","first-page":"4092","article-title":"Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors","volume":"9","author":"Murren","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_344","doi-asserted-by":"crossref","unstructured":"Kunos, C.A., Chu, E., Makower, D., Kaubisch, A., Sznol, M., and Ivy, S.P. (2017). Phase I Trial of Triapine\u2013Cisplatin\u2013Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers. Front. Oncol., 7.","DOI":"10.3389\/fonc.2017.00062"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-016-3200-x","article-title":"Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies","volume":"79","author":"Kunos","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13550-020-00621-5","article-title":"Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: A review of current evidence and discussion of the retention mechanisms","volume":"10","author":"Liu","year":"2020","journal-title":"EJNMMI Res."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ijrobp.2014.11.029","article-title":"Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion","volume":"91","author":"Nyflot","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2967\/jnumed.109.069021","article-title":"Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer","volume":"50","author":"Lohith","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s10350-008-9420-3","article-title":"Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: A pilot study","volume":"51","author":"Dietz","year":"2008","journal-title":"Dis. Colon Rectum"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1097\/RLU.0b013e3182a756f0","article-title":"Usefulness of 64Cu-ATSM in head and neck cancer: A preliminary prospective study","volume":"39","author":"Grassi","year":"2014","journal-title":"Clin. Nucl. Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/852\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:32:59Z","timestamp":1760164379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/8\/852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":350,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["biomedicines9080852"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9080852","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}